PPARs and lipid ligands in inflammation and metabolism.
作者信息
Harmon Gregory S, Lam Michael T, Glass Christopher K
机构信息
Department of Medicine, Division of Digestive Diseases, University of California-Los Angeles, Los Angeles, California 90095, USA.
出版信息
Chem Rev. 2011 Oct 12;111(10):6321-40. doi: 10.1021/cr2001355.
Abstract
摘要
相似文献
1
PPARs and lipid ligands in inflammation and metabolism.
Chem Rev. 2011 Oct 12;111(10):6321-40. doi: 10.1021/cr2001355.
2
The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):237-41.
3
Peroxisome proliferator-activated receptors and inflammation.
Pharmacol Ther. 2006 Jun;110(3):371-85. doi: 10.1016/j.pharmthera.2005.08.007. Epub 2005 Sep 15.
4
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
Annu Rev Cell Dev Biol. 2004;20:455-80. doi: 10.1146/annurev.cellbio.20.012103.134432.
5
Peroxisome proliferator-activated receptors and atherosclerosis.
Angiology. 2011 Oct;62(7):523-34. doi: 10.1177/0003319711401012. Epub 2011 Apr 5.
6
PPARs at the crossroads of lipid signaling and inflammation.
Trends Endocrinol Metab. 2012 Jul;23(7):351-63. doi: 10.1016/j.tem.2012.05.001. Epub 2012 Jun 14.
7
Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Am J Clin Dermatol. 2008;9(1):15-31. doi: 10.2165/00128071-200809010-00002.
8
PPARs: fatty acid sensors controlling metabolism.
Semin Cell Dev Biol. 2012 Aug;23(6):631-9. doi: 10.1016/j.semcdb.2012.01.003. Epub 2012 Jan 18.
9
Gaining weight: the Keystone Symposium on PPAR and LXR.
Genes Dev. 2005 Aug 1;19(15):1737-42. doi: 10.1101/gad.1341005.
10
Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives.
Cell Mol Life Sci. 2007 Oct;64(19-20):2459-64. doi: 10.1007/s00018-007-7278-5.
引用本文的文献
1
Immunometabolic Targets in CD8 T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma.
Liver Cancer. 2024 Nov 21;14(4):474-496. doi: 10.1159/000542578. eCollection 2025 Aug.
2
PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding.
Oncogene. 2025 Sep;44(37):3476-3492. doi: 10.1038/s41388-025-03492-z. Epub 2025 Jul 26.
3
Metabolic-Associated Steatotic Liver Disease: From Molecular Mechanisms to Novel Therapies.
Int J Hepatol. 2025 Jun 23;2025:5580454. doi: 10.1155/ijh/5580454. eCollection 2025.
4
Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy.
Indian J Clin Biochem. 2025 Apr;40(2):165-175. doi: 10.1007/s12291-023-01166-9. Epub 2024 Jan 8.
5
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.
EMBO Mol Med. 2025 May;17(5):938-966. doi: 10.1038/s44321-025-00216-4. Epub 2025 Mar 21.
6
Utilization of Cannabidiol in Post-Organ-Transplant Care.
Int J Mol Sci. 2025 Jan 15;26(2):699. doi: 10.3390/ijms26020699.
7
Ionizing Radiation Dose Differentially Affects the Host-Microbe Relationship over Time.
Microorganisms. 2024 Sep 30;12(10):1995. doi: 10.3390/microorganisms12101995.
8
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
9
Qing-Luo-Yin Eased Adjuvant-Induced Arthritis by Inhibiting SIRT1-Controlled Visfatin Production in White Adipose Tissues.
J Inflamm Res. 2024 Sep 24;17:6691-6706. doi: 10.2147/JIR.S474329. eCollection 2024.
10
Fenofibrate-promoted hepatomegaly and liver regeneration are PPAR-dependent and partially related to the YAP pathway.
Acta Pharm Sin B. 2024 Jul;14(7):2992-3008. doi: 10.1016/j.apsb.2024.03.030. Epub 2024 Mar 26.
本文引用的文献
1
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.
BMJ. 2011 Mar 17;342:d1309. doi: 10.1136/bmj.d1309.
2
The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.
EMBO J. 2010 Oct 6;29(19):3395-407. doi: 10.1038/emboj.2010.197. Epub 2010 Aug 17.
3
Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid.
Mol Cell. 2010 Aug 13;39(3):421-32. doi: 10.1016/j.molcel.2010.07.022.
4
15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.
Cancer Biol Ther. 2010 Oct 15;10(8):780-7. doi: 10.4161/cbt.10.8.12896.
5
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.
Arch Intern Med. 2010 Jul 26;170(14):1191-1201. doi: 10.1001/archinternmed.2010.207.
6
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291.
7
Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.
J Biol Chem. 2010 Jul 16;285(29):22067-74. doi: 10.1074/jbc.M109.085118. Epub 2010 Apr 16.
8
Conjugated linoleic acid and inflammatory cell signalling.
Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):199-204. doi: 10.1016/j.plefa.2010.02.021. Epub 2010 Mar 7.
9
Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.
Immunity. 2010 Mar 26;32(3):317-28. doi: 10.1016/j.immuni.2010.02.008. Epub 2010 Mar 4.
10
Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.
Mol Cell Biol. 2010 May;30(9):2078-89. doi: 10.1128/MCB.01651-09. Epub 2010 Feb 22.
Zotero 插件